medRxivGenetic & Genomic MedicinePreprint
Diffuse generalized phenotype of hypertrophic cardiomyopathy: genetic spectrum and surgical correction
Dzemeshkevich SliD, Maria S. BalashovaiD, Margarita E. PolyakiD, S.E. SolovyevaiD, Elena A. MershinaiD, Nataliya P. KotlukovaiD, Elena V. ZaklyazminskayaiD
Abstract
IntroductionHypertrophic cardiomyopathy (HCM) is characterized by clinical and genetic heterogeneity. Age of manifestation, clinical and anatomical phenotypes of HCM vary significantly. This study discusses genetic causes and reconstructive surgery results for patients with particular intracardiac phenotype - diffused generalized HCM (DG-HCM). Methodspersonal and familial medical history, general examination, 12-lead resting ECG, 24-hour ECG Holter monitoring, transthoracic and transesophageal EchoCG, cardiac MRI with gadolinium enhancement. A ten-gene panel was sequenced by IonTorrent PGM. Mutational screening in patients with suspected multisystemic diseases was performed by Sanger sequencing. Results170 patients with obstructive HCM (oHCM) requesting genetic counseling and surgical correction of HCM were evaluated. We distinguished particular DG-HCM subtype of oHCM (diffuse hypertrophy of IVS, LV free walls, papillary muscles displaced towards the LV apex) in 34 patients; 31 out of 34 underwent open heart reconstructive surgery. Patients with DG-HCM were younger at the time of surgery, had higher risk of SCD, and connective tissue dysplasia of the mitral valve. Hemodynamics normalization was observed in 1, 3, and 5 years after surgery. Eighteen ICDs were implanted; five patients experienced appropriate shocks. The genetic spectrum was enriched up to 30% by multisystem disorders. Mutations in "sarcomeric" genes were detected in 15%. ConclusionIntracardiac phenotype of HCM may correlate with genetic cause and long-term prognosis. DG-HCM phenotype accounts for 20% oHCM patients and indications for open-heart surgery. Extended myectomy with parietal resection of papillary muscles and correction of mitral valve insufficiency provides long-term benefits for DG-HCM patients. Multisystem disorders in patients with DG-HCM should be of special attention. Study was supported by research project FURG-2024-0004.
- organism: human
- assay: electronic health records
- research focus: differential expression
- approach: statistical model
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Genetic, Clinical, and Sociodemographic Profile in Individuals with Diagnosis or Family History of Hypertrophic Cardiomyopathy: Insights from a Prospective Cohort
Emerson de Santana Santos, Gabriel da Costa Kuhn, … Joselina Luzia Menezes Oliveira·GenesPeer-reviewed·Sep 17, 2025
- Genotype-Phenotype Correlations Identify Phenotypic Differences in Sarcomere Mutation-Positive Hypertrophic Cardiomyopathy in the NHLBI HCM Registry
Jonathan Chan, Christopher Grace, … Anuj Goel·medRxiv·Jul 30, 2026
- Patient-Derived hiPSC-Cardiomyocytes and Engineered Heart Tissues Reveal Distinct Functional Phenotypes in Inherited Cardiomyopathies
Saana Pohjavaara, Qasim A. Majid, … Virpi Talman·bioRxiv·Sep 4, 2026
- Outcomes and phenotypic expression of rare variants in hypertrophic cardiomyopathy genes amongst UK Biobank participants
Antonio de Marvao, Kathryn A. McGurk, … Declan P. O’Regan·Journal of the American College of CardiologyPeer-reviewed·Sep 1, 2021
- An Evidence-based Assessment of Genes in Dilated Cardiomyopathy
Elizabeth Jordan, Laiken Peterson, … Ray E. Hershberger·CirculationPeer-reviewed·May 5, 2021
- Reclassification of Genetic Variants in Patients with Hypertrophic Cardiomyopathy from the Sarcomeric Human Cardiomyopathy Registry (SHaRe)
Sophie Hespe, G. Powell, … Jodie Ingles·Heart Lung and CirculationPeer-reviewed·Jul 30, 2026